Navigation Links
Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
Date:5/19/2009

clude, among other things, statements regarding clinical trials, regulatory approvals, competitive offerings and product performance. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to al
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
2. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
3. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
4. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
5. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
6. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
7. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
8. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
9. Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008
10. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
11. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014 Thoratec Corporation (NASDAQ: ... circulatory support therapies to save, support and restore failing ... has been appointed President and Chief Executive Officer, effective ... has stepped down from his executive and Board roles ... through the first quarter of 2016.  ...
(Date:9/22/2014)... 22, 2014 Research and Markets  has ... Diclofenac Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... a focus on the Chinese situation. The ... definitions, classifications, applications and industry chain structure. The diclofenac ...
(Date:9/22/2014)... SHENZHEN, China , Sept. 22, 2014 China Nepstar ... "Company"), a leading retail drugstore chain in China ... that it will hold its 2014 Annual General Meeting of Shareholders ... The AGM will be held at the meeting room of the ... District, Shenzhen , Guangdong Province ...
Breaking Medicine Technology:Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 2Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 4Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 5Global and Chinese Diclofenac Industry Report 2014 2China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 22, 2014 2
... 3, 2010 The American College of Radiology (ACR) distributed ... ( MCR5 ) educational CD-ROM free of charge to physicians ... Mammography Case Review ( MCR5 ... improve their skills regarding the detection of cancers and other ...
... contract research organization will expand its operations in Chester County ... the Department of Community and Economic Development announced today. ... in Wayne, purchase new equipment and provide employee training. The ... three years and retain 80 existing positions.   ...
Cached Medicine Technology:ACR Distributes Free High-Tech Mammography Education Tool to NY Facilities 2Research Facility Expansion Will Create, Retain More than 150 Jobs in Chester County 2
(Date:9/22/2014)... 22, 2014 (HealthDay News) -- Teens and young adults ... behavioral counseling to help prevent risky sexual behaviors, according ... Force. Every year, about 20 million new sexually ... the United States. About half involve people between 15 ... Its new report, published Sept. 22 in ...
(Date:9/22/2014)... study pulls back the curtain on one of the ... and income between physicians who perform operations, procedures or ... perception, the research indicates, the physician payment system is ... doctors. , The new findings counter the widely held ... explains why doctors who perform procedures often earn nearly ...
(Date:9/22/2014)... September 22, 2014 Manhattan residents who ... side of the hip , which could be bursitis ... This treatment is now offered at New York Dynamic ... called trochanteric bursitis, occurs when the trochanteric bursa becomes ... in the hip, between the iliotibial band and the ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. 22, 2014 ... 6 months and older be vaccinated for the upcoming flu ... vaccine recommendations to advise that the youngest kids should have ... also wants parents of children aged 2 to 8 to ... the flu shot if it,s readily available. "It,s important ...
(Date:9/22/2014)... MA Up to 40 percent of patients undergoing ... fail to remove all the cancerous tissue in the ... (BWH) have successfully tested a tool they developed that ... normal tissue, thereby decreasing the chances for repeat operations. ... the week of September 22, 2014 in the ...
Breaking Medicine News(10 mins):Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 2Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 3Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 2Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 3Health News:The fine line between breast cancer and normal tissues 2
... States,Agency for International Development (USAID) is pleased to ... reduces the risk of,diarrhea. Sur,Eau is a water ... can be added to water immediately before,use and ... children and,people living with HIV and AIDS -- ...
... SAN DIEGO, April 25 SynergEyes, Inc., of ... designed for people,who need further vision correction after ... designed for patients who,have experienced some type of ... Every year, millions of people undergo LASIK ...
... Nonprofit Health Systems Research Institute as New Vice ... ... leader,and advocate on HIV/AIDS issues, has joined the nonprofit Altarum Institute,as Vice ... began the search for someone to lead our Community Health,Systems Group, I ...
... Comments Made by TV Game Show Host Spark Controversy, ... long-time host of,the television game show "The Price Is ... (CDOC), a non-profit group formed to,support responsible dog ownership. ... neuter law that went into effect this month in ...
... North Carolina-based Oaks,Development Group announced today ... Olympia Avenue, in Punta Gorda, Florida. The,29,927-square-foot ... near,Charlotte Regional Medical Center and currently includes ... converted to Oaks, unique,tenant-ownership model., Oaks, ...
... Tanzania, April 25 Today is a,great day for the ... a day to,celebrate. We celebrate because of the possibilities that ... by the United,Nations Secretary General His Excellency Ban Ki-Moon, presents ... is implemented to the,letter, millions of lives will be saved ...
Cached Medicine News:Health News:Disinfecting Water Saves Lives in Rwanda 2Health News:SynergEyes Hybrid Contact Lenses Provide a Vision Solution for Post-LASIK Patients 2Health News:Prominent Advocate on HIV/AIDS Issues Joins Altarum Institute 2Health News:Bob Barker's 'Right' to Free Speech Comes with a 'Price' 2Health News:Oaks Development Group Acquires Medical Office Building in Punta Gorda, Florida 2Health News:Statement by H.E. Jakaya Mrisho Kikwete, President of the United Republic of Tanzania, and Chairman of the African Union, in Response to UN-SG Call to Action on Malaria 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: